CircoMax Myco

RSS

Authorised

This medicine is authorised for use in the European Union

porcine circovirus vaccine (inactivated, recombinant) / mycoplasma hyopneumoniae vaccine (inactivated)
MedicineVeterinaryAuthorised

French is available via eTranslation, the European Commission's machine translation service.

Translate to French | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Product details

Name of medicine
CircoMax Myco
Active substance
  • Inactivated Mycoplasma hyopneumoniae, strain P-5722-3
  • inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (ORF2) protein
  • inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b ORF2 protein
International non-proprietary name (INN) or common name
  • porcine circovirus vaccine (inactivated, recombinant)
  • mycoplasma hyopneumoniae vaccine (inactivated)

Pharmacotherapeutic group

  • Immunologicals for suidae
  • Inactivated viral and inactivated bacterial vaccines

Authorisation details

EMA product number
EMEA/V/C/005184

Assessment history

CVMP post-authorisation summary of positive opinion for CircoMax Myco

Adopted Reference Number: EMA/CVMP/452705/2023

English (EN) (137.91 Ko - PDF)

Première publication:
Voir

CVMP summary of positive opinion for CircoMax Myco

Adopted Reference Number: EMA/CVMP/495892/2020

English (EN) (66.58 Ko - PDF)

Première publication:
Voir
This page was last updated on

Share this page